The estimated Net Worth of Joseph Michael Fitzgerald is at least $38.5 Milione dollars as of 28 August 2024. Mr. Fitzgerald owns over 14,132 units of Boston Scientific stock worth over $14,626,884 and over the last 15 years he sold BSX stock worth over $19,873,672. In addition, he makes $4,025,460 as Executive Vice President, President e Interventional Cardiology at Boston Scientific.
Joseph has made over 91 trades of the Boston Scientific stock since 2010, according to the Form 4 filled with the SEC. Most recently he sold 14,132 units of BSX stock worth $1,130,560 on 28 August 2024.
The largest trade he's ever made was exercising 107,692 units of Boston Scientific stock on 13 December 2019 worth over $797,998. On average, Joseph trades about 12,989 units every 47 days since 2010. As of 28 August 2024 he still owns at least 176,355 units of Boston Scientific stock.
You can see the complete history of Mr. Fitzgerald stock trades at the bottom of the page.
Joseph M. Fitzgerald has been appointed as Executive Vice President, President, Interventional Cardiology of the Company effective 7/6/2020. He is our executive vice president and president, Rhythm Management, a position he has held since February 2014, having previously served as senior vice president and president, Cardiac Rhythm Management from July 2011. He served as senior vice president and president, Endovascular from February 2010 until July 2011. Prior to that, Mr. Fitzgerald was president and general manager of Peripheral Interventions and president of Electrophysiology. Mr. Fitzgerald held a variety of management positions in our Neurovascular and Peripheral Interventions businesses. These included numerous regional and divisional sales management assignments up to and including his roles as vice president, Global Marketing for the Neurovascular business and vice president of U.S. Sales for the Neurovascular business. Prior to joining Boston Scientific in 1990 as a sales representative, Mr. Fitzgerald was with Anheuser Busch, Inc., where he held a variety of sales, marketing and training assignments. Mr. Fitzgerald holds a B.S. in Business from Indiana University and an M.B.A. from Southern Illinois University with a concentration in Marketing and Finance.
As the Executive Vice President, President e Interventional Cardiology of Boston Scientific, the total compensation of Joseph Fitzgerald at Boston Scientific is $4,025,460. There are 2 executives at Boston Scientific getting paid more, with Michael Mahoney having the highest compensation of $15,764,100.
Joseph Fitzgerald is 56, he's been the Executive Vice President, President e Interventional Cardiology of Boston Scientific since 2020. There are 12 older and 14 younger executives at Boston Scientific. The oldest executive at Boston Scientific Corp. is Yoshiaki Fujimori, 69, who is the Independent Director.
Joseph's mailing address filed with the SEC is 300 BOSTON SCIENTIFIC WAY, , MARLBOROUGH, MA, 01752-1234.
Over the last 19 years, insiders at Boston Scientific have traded over $938,841,783 worth of Boston Scientific stock and bought 1,398,972 units worth $16,231,539 . The most active insiders traders include Peter M Nicholas, John E Abele e Michael F Mahoney. On average, Boston Scientific executives and independent directors trade stock every 3 days with the average trade being worth of $4,899,929. The most recent stock trade was executed by Michael F Mahoney on 5 September 2024, trading 162,777 units of BSX stock currently worth $13,212,609.
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
Boston Scientific executives and other stock owners filed with the SEC include: